Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 4585 entries
Sorted by: Best Match Show Resources per page
Half-life systematics across the N=126 shell closure: role of first-forbidden transitions in the β decay of heavy neutron-rich nuclei.

Physical review letters

Morales AI, Benlliure J, Kurtukián-Nieto T, Schmidt KH, Verma S, Regan PH, Podolyák Z, Górska M, Pietri S, Kumar R, Casarejos E, Al-Dahan N, Algora A, Alkhomashi N, Álvarez-Pol H, Benzoni G, Blazhev A, Boutachkov P, Bruce AM, Cáceres LS, Cullen IJ, Denis Bacelar AM, Doornenbal P, Estévez-Aguado ME, Farrelly G, Fujita Y, Garnsworthy AB, Gelletly W, Gerl J, Grebosz J, Hoischen R, Kojouharov I, Kurz N, Lalkovski S, Liu Z, Mihai C, Molina F, Mücher D, Rubio B, Shaffner H, Steer SJ, Tamii A, Tashenov S, Valiente-Dobón JJ, Walker PM, Wollersheim HJ, Woods PJ.
PMID: 25062171
Phys Rev Lett. 2014 Jul 11;113(2):022702. doi: 10.1103/PhysRevLett.113.022702. Epub 2014 Jul 11.

This Letter reports on a systematic study of β-decay half-lives of neutron-rich nuclei around doubly magic (208)Pb. The lifetimes of the 126-neutron shell isotone (204)Pt and the neighboring (200-202)Ir, (203)Pt, (204)Au are presented together with other 19 half-lives measured...

Cite
Morales AI, Benlliure J, Kurtukián-Nieto T, et al. Half-life systematics across the N=126 shell closure: role of first-forbidden transitions in the β decay of heavy neutron-rich nuclei. Phys Rev Lett. 2014;113(2):022702doi: 10.1103/PhysRevLett.113.022702.
Morales, A. I., Benlliure, J., Kurtukián-Nieto, T., Schmidt, K. H., Verma, S., Regan, P. H., Podolyák, Z., Górska, M., Pietri, S., Kumar, R., Casarejos, E., Al-Dahan, N., Algora, A., Alkhomashi, N., Álvarez-Pol, H., Benzoni, G., Blazhev, A., Boutachkov, P., Bruce, A. M., Cáceres, L. S., Cullen, I. J., Denis Bacelar, A. M., Doornenbal, P., Estévez-Aguado, M. E., Farrelly, G., Fujita, Y., Garnsworthy, A. B., Gelletly, W., Gerl, J., Grebosz, J., Hoischen, R., Kojouharov, I., Kurz, N., Lalkovski, S., Liu, Z., Mihai, C., Molina, F., Mücher, D., Rubio, B., Shaffner, H., Steer, S. J., Tamii, A., Tashenov, S., Valiente-Dobón, J. J., Walker, P. M., Wollersheim, H. J., & Woods, P. J. (2014). Half-life systematics across the N=126 shell closure: role of first-forbidden transitions in the β decay of heavy neutron-rich nuclei. Physical review letters, 113(2), 022702. https://doi.org/10.1103/PhysRevLett.113.022702
Morales, A I, et al. "Half-life systematics across the N=126 shell closure: role of first-forbidden transitions in the β decay of heavy neutron-rich nuclei." Physical review letters vol. 113,2 (2014): 022702. doi: https://doi.org/10.1103/PhysRevLett.113.022702
Morales AI, Benlliure J, Kurtukián-Nieto T, Schmidt KH, Verma S, Regan PH, Podolyák Z, Górska M, Pietri S, Kumar R, Casarejos E, Al-Dahan N, Algora A, Alkhomashi N, Álvarez-Pol H, Benzoni G, Blazhev A, Boutachkov P, Bruce AM, Cáceres LS, Cullen IJ, Denis Bacelar AM, Doornenbal P, Estévez-Aguado ME, Farrelly G, Fujita Y, Garnsworthy AB, Gelletly W, Gerl J, Grebosz J, Hoischen R, Kojouharov I, Kurz N, Lalkovski S, Liu Z, Mihai C, Molina F, Mücher D, Rubio B, Shaffner H, Steer SJ, Tamii A, Tashenov S, Valiente-Dobón JJ, Walker PM, Wollersheim HJ, Woods PJ. Half-life systematics across the N=126 shell closure: role of first-forbidden transitions in the β decay of heavy neutron-rich nuclei. Phys Rev Lett. 2014 Jul 11;113(2):022702. doi: 10.1103/PhysRevLett.113.022702. Epub 2014 Jul 11. PMID: 25062171.
Copy Download .nbib Format: NLM
Lung cancer with spontaneous regression of primary and metastatic sites: A case report.

Oncology letters

Ogawa R, Watanabe H, Yazaki K, Fujita K, Tsunoda Y, Nakazawa K, Homma S, Kagohashi K, Satoh H, Hizawa N.
PMID: 26171067
Oncol Lett. 2015 Jul;10(1):550-552. doi: 10.3892/ol.2015.3243. Epub 2015 May 20.

Partial or complete spontaneous cancer regression is a rare phenomenon, particularly in patients with lung cancer. This is the case report of a patient with lung cancer who exhibited spontaneous regression of the primary as well as metastatic lesions,...

Cite
Ogawa R, Watanabe H, Yazaki K, et al. Lung cancer with spontaneous regression of primary and metastatic sites: A case report. Oncol Lett. 2015;10(1):550-552doi: 10.3892/ol.2015.3243.
Ogawa, R., Watanabe, H., Yazaki, K., Fujita, K., Tsunoda, Y., Nakazawa, K., Homma, S., Kagohashi, K., Satoh, H., & Hizawa, N. (2015). Lung cancer with spontaneous regression of primary and metastatic sites: A case report. Oncology letters, 10(1), 550-552. https://doi.org/10.3892/ol.2015.3243
Ogawa, Ryoko, et al. "Lung cancer with spontaneous regression of primary and metastatic sites: A case report." Oncology letters vol. 10,1 (2015): 550-552. doi: https://doi.org/10.3892/ol.2015.3243
Ogawa R, Watanabe H, Yazaki K, Fujita K, Tsunoda Y, Nakazawa K, Homma S, Kagohashi K, Satoh H, Hizawa N. Lung cancer with spontaneous regression of primary and metastatic sites: A case report. Oncol Lett. 2015 Jul;10(1):550-552. doi: 10.3892/ol.2015.3243. Epub 2015 May 20. PMID: 26171067; PMCID: PMC4487128.
Copy Download .nbib Format: NLM
Ultrasonographic findings and natural history of intraductal papillary-mucinous neoplasms of the pancreas.

Journal of medical ultrasonics (2001)

Kobayashi G, Fujita N, Noda Y, Obana T, Takasawa O.
PMID: 27278830
J Med Ultrason (2001). 2008 Sep;35(3):85-96. doi: 10.1007/s10396-008-0188-9. Epub 2008 Sep 19.

It is clear that the prevalence of malignancy is high in the main-duct type of intraductal papillary-mucinous neoplasm (IPMN). Branch-duct IPMNs include several histologic conditions such as carcinoma, adenoma, and hyperplasia. Intraductal papillary adenocarcinoma and papillary adenoma are characterized...

Cite
Kobayashi G, Fujita N, Noda Y, et al. Ultrasonographic findings and natural history of intraductal papillary-mucinous neoplasms of the pancreas. J Med Ultrason (2001). 2008;35(3):85-96doi: 10.1007/s10396-008-0188-9.
Kobayashi, G., Fujita, N., Noda, Y., Obana, T., & Takasawa, O. (2008). Ultrasonographic findings and natural history of intraductal papillary-mucinous neoplasms of the pancreas. Journal of medical ultrasonics (2001), 35(3), 85-96. https://doi.org/10.1007/s10396-008-0188-9
Kobayashi, Go, et al. "Ultrasonographic findings and natural history of intraductal papillary-mucinous neoplasms of the pancreas." Journal of medical ultrasonics (2001) vol. 35,3 (2008): 85-96. doi: https://doi.org/10.1007/s10396-008-0188-9
Kobayashi G, Fujita N, Noda Y, Obana T, Takasawa O. Ultrasonographic findings and natural history of intraductal papillary-mucinous neoplasms of the pancreas. J Med Ultrason (2001). 2008 Sep;35(3):85-96. doi: 10.1007/s10396-008-0188-9. Epub 2008 Sep 19. PMID: 27278830.
Copy Download .nbib Format: NLM
Draft Genome Sequence of Nonomuraea sp. TP-A0861, a Producer of Myxochelin A.

Genome announcements

Komaki H, Ichikawa N, Hosoyama A, Fujita N, Igarashi Y.
PMID: 26659677
Genome Announc. 2015 Dec 10;3(6). doi: 10.1128/genomeA.01430-15.

Nonomuraea sp. TP-A0861 produces the nonribosomal peptide myxochelin A, which is known as a microbial siderophore. Here, we report its draft genome sequence. The genome contains at least three nonribosomal peptide synthetase gene clusters, one of which is proposed...

Cite
Komaki H, Ichikawa N, Hosoyama A, et al. Draft Genome Sequence of Nonomuraea sp. TP-A0861, a Producer of Myxochelin A. Genome Announc. 2015;3(6)doi: 10.1128/genomeA.01430-15.
Komaki, H., Ichikawa, N., Hosoyama, A., Fujita, N., & Igarashi, Y. (2015). Draft Genome Sequence of Nonomuraea sp. TP-A0861, a Producer of Myxochelin A. Genome announcements, 3(6), . https://doi.org/10.1128/genomeA.01430-15
Komaki, Hisayuki, et al. "Draft Genome Sequence of Nonomuraea sp. TP-A0861, a Producer of Myxochelin A." Genome announcements vol. 3,6 (2015). doi: https://doi.org/10.1128/genomeA.01430-15
Komaki H, Ichikawa N, Hosoyama A, Fujita N, Igarashi Y. Draft Genome Sequence of Nonomuraea sp. TP-A0861, a Producer of Myxochelin A. Genome Announc. 2015 Dec 10;3(6). doi: 10.1128/genomeA.01430-15. PMID: 26659677; PMCID: PMC4675942.
Copy Download .nbib Format: NLM
Evaluation in monkey of two candidate PET radioligands, [.

Synapse (New York, N.Y.)

Lohith TG, Xu R, Tsujikawa T, Morse CL, Anderson KB, Gladding RL, Zoghbi SS, Fujita M, Innis RB, Pike VW.
PMID: 25088028
Synapse. 2014 Dec;68(12):613-623. doi: 10.1002/syn.21773. Epub 2014 Aug 11.

The serotonin subtype-4 (5-HT

Cite
Lohith TG, Xu R, Tsujikawa T, et al. Evaluation in monkey of two candidate PET radioligands, [. Synapse. 2014;68(12):613-623doi: 10.1002/syn.21773.
Lohith, T. G., Xu, R., Tsujikawa, T., Morse, C. L., Anderson, K. B., Gladding, R. L., Zoghbi, S. S., Fujita, M., Innis, R. B., & Pike, V. W. (2014). Evaluation in monkey of two candidate PET radioligands, [. Synapse (New York, N.Y.), 68(12), 613-623. https://doi.org/10.1002/syn.21773
Lohith, Talakad G, et al. "Evaluation in monkey of two candidate PET radioligands, [." Synapse (New York, N.Y.) vol. 68,12 (2014): 613-623. doi: https://doi.org/10.1002/syn.21773
Lohith TG, Xu R, Tsujikawa T, Morse CL, Anderson KB, Gladding RL, Zoghbi SS, Fujita M, Innis RB, Pike VW. Evaluation in monkey of two candidate PET radioligands, [. Synapse. 2014 Dec;68(12):613-623. doi: 10.1002/syn.21773. Epub 2014 Aug 11. PMID: 25088028; PMCID: PMC4317381.
Copy Download .nbib Format: NLM
Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis.

Hepatology research : the official journal of the Japan Society of Hepatology

Naeshiro N, Aikata H, Hyogo H, Kan H, Fujino H, Kobayashi T, Fukuhara T, Honda Y, Nakahara T, Ohno A, Miyaki D, Murakami E, Kawaoka T, Tsuge M, Hiraga N, Hiramatsu A, Imamura M, Kawakami Y, Ochi H, Chayama K.
PMID: 25088236
Hepatol Res. 2015 Jun;45(6):656-62. doi: 10.1111/hepr.12400. Epub 2014 Sep 02.

AIM: To assess the efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis (PVT) in patients with liver cirrhosis.METHODS: A consecutive 26 cirrhotic patients with PVT were enrolled in this retrospective cohort...

Cite
Naeshiro N, Aikata H, Hyogo H, et al. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. Hepatol Res. 2014;45(6):656-62doi: 10.1111/hepr.12400.
Naeshiro, N., Aikata, H., Hyogo, H., Kan, H., Fujino, H., Kobayashi, T., Fukuhara, T., Honda, Y., Nakahara, T., Ohno, A., Miyaki, D., Murakami, E., Kawaoka, T., Tsuge, M., Hiraga, N., Hiramatsu, A., Imamura, M., Kawakami, Y., Ochi, H., & Chayama, K. (2015). Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. Hepatology research : the official journal of the Japan Society of Hepatology, 45(6), 656-62. https://doi.org/10.1111/hepr.12400
Naeshiro, Noriaki, et al. "Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis." Hepatology research : the official journal of the Japan Society of Hepatology vol. 45,6 (2015): 656-62. doi: https://doi.org/10.1111/hepr.12400
Naeshiro N, Aikata H, Hyogo H, Kan H, Fujino H, Kobayashi T, Fukuhara T, Honda Y, Nakahara T, Ohno A, Miyaki D, Murakami E, Kawaoka T, Tsuge M, Hiraga N, Hiramatsu A, Imamura M, Kawakami Y, Ochi H, Chayama K. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. Hepatol Res. 2015 Jun;45(6):656-62. doi: 10.1111/hepr.12400. Epub 2014 Sep 02. PMID: 25088236.
Copy Download .nbib Format: NLM
A Compendium for Mycoplasma pneumoniae.

Frontiers in microbiology

Parrott GL, Kinjo T, Fujita J.
PMID: 27148202
Front Microbiol. 2016 Apr 12;7:513. doi: 10.3389/fmicb.2016.00513. eCollection 2016.

Historically, atypical pneumonia was a term used to describe an unusual presentation of pneumonia. Currently, it is used to describe the multitude of symptoms juxtaposing the classic symptoms found in cases of pneumococcal pneumonia. Specifically, atypical pneumonia is a...

Cite
Parrott GL, Kinjo T, Fujita J. A Compendium for Mycoplasma pneumoniae. Front Microbiol. 2016;7:513doi: 10.3389/fmicb.2016.00513.
Parrott, G. L., Kinjo, T., & Fujita, J. (2016). A Compendium for Mycoplasma pneumoniae. Frontiers in microbiology, 7513. https://doi.org/10.3389/fmicb.2016.00513
Parrott, Gretchen L, et al. "A Compendium for Mycoplasma pneumoniae." Frontiers in microbiology vol. 7 (2016): 513. doi: https://doi.org/10.3389/fmicb.2016.00513
Parrott GL, Kinjo T, Fujita J. A Compendium for Mycoplasma pneumoniae. Front Microbiol. 2016 Apr 12;7:513. doi: 10.3389/fmicb.2016.00513. eCollection 2016. PMID: 27148202; PMCID: PMC4828434.
Copy Download .nbib Format: NLM
Effects of scallop shell extract on scopolamine-induced memory impairment and MK801-induced locomotor activity.

Asian Pacific journal of tropical medicine

Hasegawa Y, Inoue T, Kawaminami S, Fujita M.
PMID: 27393094
Asian Pac J Trop Med. 2016 Jul;9(7):662-7. doi: 10.1016/j.apjtm.2016.05.019. Epub 2016 May 31.

OBJECTIVE: To evaluate the neuroprotective effects of the organic components of scallop shells (scallop shell extract) on memory impairment and locomotor activity induced by scopolamine or 5-methyl-10,11-dihydro-5H-dibenzo (a,d) cyclohepten-5,10-imine (MK801).METHODS: Effect of the scallop shell extract on memory impairment...

Cite
Hasegawa Y, Inoue T, Kawaminami S, et al. Effects of scallop shell extract on scopolamine-induced memory impairment and MK801-induced locomotor activity. Asian Pac J Trop Med. 2016;9(7):662-7doi: 10.1016/j.apjtm.2016.05.019.
Hasegawa, Y., Inoue, T., Kawaminami, S., & Fujita, M. (2016). Effects of scallop shell extract on scopolamine-induced memory impairment and MK801-induced locomotor activity. Asian Pacific journal of tropical medicine, 9(7), 662-7. https://doi.org/10.1016/j.apjtm.2016.05.019
Hasegawa, Yasushi, et al. "Effects of scallop shell extract on scopolamine-induced memory impairment and MK801-induced locomotor activity." Asian Pacific journal of tropical medicine vol. 9,7 (2016): 662-7. doi: https://doi.org/10.1016/j.apjtm.2016.05.019
Hasegawa Y, Inoue T, Kawaminami S, Fujita M. Effects of scallop shell extract on scopolamine-induced memory impairment and MK801-induced locomotor activity. Asian Pac J Trop Med. 2016 Jul;9(7):662-7. doi: 10.1016/j.apjtm.2016.05.019. Epub 2016 May 31. PMID: 27393094.
Copy Download .nbib Format: NLM
Fournier's gangrene caused by Listeria monocytogenes as the primary organism.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale

Asahata S, Hirai Y, Ainoda Y, Fujita T, Okada Y, Kikuchi K.
PMID: 25798155
Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26(1):44-6. doi: 10.1155/2015/501386.

A 70-year-old man with a history of tongue cancer presented with Fournier's gangrene caused by Listeria monocytogenes serotype 4b. Surgical debridement revealed undiagnosed rectal adenocarcinoma. The patient did not have an apparent dietary or travel history but reported daily...

Cite
Asahata S, Hirai Y, Ainoda Y, et al. Fournier's gangrene caused by Listeria monocytogenes as the primary organism. Can J Infect Dis Med Microbiol. 2015;26(1):44-6doi: 10.1155/2015/501386.
Asahata, S., Hirai, Y., Ainoda, Y., Fujita, T., Okada, Y., & Kikuchi, K. (2015). Fournier's gangrene caused by Listeria monocytogenes as the primary organism. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 26(1), 44-6. https://doi.org/10.1155/2015/501386
Asahata, Sayaka, et al. "Fournier's gangrene caused by Listeria monocytogenes as the primary organism." The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale vol. 26,1 (2015): 44-6. doi: https://doi.org/10.1155/2015/501386
Asahata S, Hirai Y, Ainoda Y, Fujita T, Okada Y, Kikuchi K. Fournier's gangrene caused by Listeria monocytogenes as the primary organism. Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26(1):44-6. doi: 10.1155/2015/501386. PMID: 25798155; PMCID: PMC4353270.
Copy Download .nbib Format: NLM
[Corrigendum] Antitumor effects of ZD6474 on head and neck squamous cell carcinoma.

Oncology reports

Sano D, Kawakami M, Fujita K, Kimura M, Yamashita Y, Ishiguro Y, Nishimura G, Matsuda H, Tsukuda M.
PMID: 26781072
Oncol Rep. 2016 Apr;35(4):2495. doi: 10.3892/or.2016.4574. Epub 2016 Jan 18.

Oncol Rep 17: [Related article:] 289–295, 2007; DOI: 10.3892/or.17.2.289 After the publication of the article, the authors noted that the relevance of the findings reported in this article on ZD6474 inhibition of growth of head and neck squamous cell...

Cite
Sano D, Kawakami M, Fujita K, et al. [Corrigendum] Antitumor effects of ZD6474 on head and neck squamous cell carcinoma. Oncol Rep. 2016;35(4):2495doi: 10.3892/or.2016.4574.
Sano, D., Kawakami, M., Fujita, K., Kimura, M., Yamashita, Y., Ishiguro, Y., Nishimura, G., Matsuda, H., & Tsukuda, M. (2016). [Corrigendum] Antitumor effects of ZD6474 on head and neck squamous cell carcinoma. Oncology reports, 35(4), 2495. https://doi.org/10.3892/or.2016.4574
Sano, Daisuke, et al. "[Corrigendum] Antitumor effects of ZD6474 on head and neck squamous cell carcinoma." Oncology reports vol. 35,4 (2016): 2495. doi: https://doi.org/10.3892/or.2016.4574
Sano D, Kawakami M, Fujita K, Kimura M, Yamashita Y, Ishiguro Y, Nishimura G, Matsuda H, Tsukuda M. [Corrigendum] Antitumor effects of ZD6474 on head and neck squamous cell carcinoma. Oncol Rep. 2016 Apr;35(4):2495. doi: 10.3892/or.2016.4574. Epub 2016 Jan 18. PMID: 26781072.
Copy Download .nbib Format: NLM
Frequency of diabetic retinopathy and related factors in patients with diabetes having coronary artery disease.

Diabetes research and clinical practice

Ohtomo K, Shigeeda T, Hirose A, Ohno T, Kinoshita O, Fujita H, Ando J, Nagai R, Takamoto S, Kadowaki T, Kato S.
PMID: 27371781
Diabetes Res Clin Pract. 2016 Aug;118:154-5. doi: 10.1016/j.diabres.2016.06.016. Epub 2016 Jun 17.

No abstract available.

Cite
Ohtomo K, Shigeeda T, Hirose A, et al. Frequency of diabetic retinopathy and related factors in patients with diabetes having coronary artery disease. Diabetes Res Clin Pract. 2016;118:154-5doi: 10.1016/j.diabres.2016.06.016.
Ohtomo, K., Shigeeda, T., Hirose, A., Ohno, T., Kinoshita, O., Fujita, H., Ando, J., Nagai, R., Takamoto, S., Kadowaki, T., & Kato, S. (2016). Frequency of diabetic retinopathy and related factors in patients with diabetes having coronary artery disease. Diabetes research and clinical practice, 118154-5. https://doi.org/10.1016/j.diabres.2016.06.016
Ohtomo, Kazuyoshi, et al. "Frequency of diabetic retinopathy and related factors in patients with diabetes having coronary artery disease." Diabetes research and clinical practice vol. 118 (2016): 154-5. doi: https://doi.org/10.1016/j.diabres.2016.06.016
Ohtomo K, Shigeeda T, Hirose A, Ohno T, Kinoshita O, Fujita H, Ando J, Nagai R, Takamoto S, Kadowaki T, Kato S. Frequency of diabetic retinopathy and related factors in patients with diabetes having coronary artery disease. Diabetes Res Clin Pract. 2016 Aug;118:154-5. doi: 10.1016/j.diabres.2016.06.016. Epub 2016 Jun 17. PMID: 27371781.
Copy Download .nbib Format: NLM
Prolonged hypotension induced by ingesting a topical minoxidil solution: analysis of minoxidil and its metabolites.

Acute medicine & surgery

Kikuchi S, Fujita Y, Onodera M, Fujino Y, Inoue Y.
PMID: 29123818
Acute Med Surg. 2016 Mar 28;3(4):384-387. doi: 10.1002/ams2.196. eCollection 2016 Oct.

CASE: A 47-year-old man ingested 60 mL of a topical solution (3,000 mg minoxidil) and presented with prolonged hypotension. Treatment with dopamine hydrochloride and noradrenaline provided blood pressure control. Serum unchanged minoxidil concentrations at 4 and 16 h after...

Cite
Kikuchi S, Fujita Y, Onodera M, et al. Prolonged hypotension induced by ingesting a topical minoxidil solution: analysis of minoxidil and its metabolites. Acute Med Surg. 2016;3(4):384-387doi: 10.1002/ams2.196.
Kikuchi, S., Fujita, Y., Onodera, M., Fujino, Y., & Inoue, Y. (2016). Prolonged hypotension induced by ingesting a topical minoxidil solution: analysis of minoxidil and its metabolites. Acute medicine & surgery, 3(4), 384-387. https://doi.org/10.1002/ams2.196
Kikuchi, Satoshi, et al. "Prolonged hypotension induced by ingesting a topical minoxidil solution: analysis of minoxidil and its metabolites." Acute medicine & surgery vol. 3,4 (2016): 384-387. doi: https://doi.org/10.1002/ams2.196
Kikuchi S, Fujita Y, Onodera M, Fujino Y, Inoue Y. Prolonged hypotension induced by ingesting a topical minoxidil solution: analysis of minoxidil and its metabolites. Acute Med Surg. 2016 Mar 28;3(4):384-387. doi: 10.1002/ams2.196. eCollection 2016 Oct. PMID: 29123818; PMCID: PMC5667325.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 4585 entries